Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2023

Summary of Significant Accounting Policies [Abstract]

Schedule of Exchange Rates

Translation of amounts from RMB into US$ has been made at the following exchange rates for the respective periods:

	December 31, 2023		December 31, 2022
Balance sheet items, except for equity accounts		7.0999		6.8972

	For the Years Ended December 31,
	2023		2022		2021
Items in the statements of operations and comprehensive (loss) income, and statements of cash flows		7.0809		6.7290		6.4508

Schedule of Property and Equipment

Depreciation is computed using the straight-line method with residual value rate of 5% based on the estimated useful lives as follows:

Land and buildings	7 - 21 years
Office equipment	3 years
Vehicle	4 years
Leasehold improvements	5 years

Schedule of Amortized Over their Estimated Useful Lives

Separately identifiable intangible assets that have determinable lives continue to be amortized over their estimated useful lives using the straight-line method based on their estimated useful lives as follows:

Trademarks	10 years
License	10 years
Software	3 - 10 years

Schedule of Disaggregation of Our Revenue

The following table identifies the disaggregation of our revenue for the years ended December 31, 2023, 2022 and 2021, respectively.

	For the Years Ended December 31,
	2023		2022		2021
Medical training and education services	$	6,385,735	$	6,604,487	$	8,754,120
Patient management services in patient-aid projects		3,998,455		6,288,602		7,343,343
Sales of patented drugs		9,027,211		1,216,096		-
Other revenues		22,544		42,331		199,307
Total	$	19,433,945	$	14,151,516	$	16,296,770